For the first time scientists have identified promising drug candidates that bind irreversibly with a notoriously "undruggable" cancer protein target ...

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, a new study demonstrates how some cancer cells use the protein ...

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...

Scientists have finally captured footage of the microscopic machinery that allows our cells to copy DNA—a fundamental process ...

Colorectal cancer rates are rising in younger adults. Learn prevention strategies from screening to lifestyle changes that significantly reduce your risk factor ...

To protect crops from rising droughts, scientists are looking to the genes of a small group of plants that can survive months ...

With the long-term goal of creating living cells from non-living components, scientists in the field of synthetic biology work with RNA origami. This tool uses the multifunctionality of the natural ...

St. Jude researchers identified a protein, voltage-dependent anion channel 2 (VDAC2), that tumors use as a “signal jammer” to prevent cancer cell death and evade the immune system’s functioning.

A new part of an ocean plant cell has been discovered that might revolutionize farming one day. The structure can take ...

New research uncovers new insights into preventing chronic inflammation caused by aging-related zombie-like cells. In humans ...

Why Google DeepMind, Perplexity, Khan Academy, Canva, and Salesforce are among Fast Company’s Most Innovative Companies for 2025.

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...